J2313 Injection, naloxone (zimhi) 0.01mg
Also known as: naloxone, Zimhi
Injection of naloxone (Zimhi brand), 0.01 milligram. An opioid antagonist from a specific manufacturer.
In Plain Language
opioid overdose reversal; rapid antidote
Clinical Context
Used for opioid overdose reversal. Zimhi is a specific naloxone formulation providing rapid parenteral antidote effect.
RVU Information
CPT J2313 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2313?
CPT J2313 (Injection, naloxone (zimhi) 0.01mg) is a J Codes (Drugs) code. Injection of naloxone (Zimhi brand), 0.01 milligram. An opioid antagonist from a specific manufacturer.
How is J2313 administered?
CPT J2313 is administered by a healthcare provider, typically via injection or infusion. Used for opioid overdose reversal. Zimhi is a specific naloxone formulation providing rapid parenteral antidote effect. It is used by Emergency Medicine, Critical Care.
When is CPT J2313 used?
Used for opioid overdose reversal. Zimhi is a specific naloxone formulation providing rapid parenteral antidote effect.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.